340B Drug Pricing Program
The AHA on Thursday, May 15 at 3 p.m. ET will host a call for member hospitals and health systems to discuss the Department of Health and Human Services’ recent announcement that it will be “in a position to provide guidance” about the drug industry’s proposed use of “rebate models” by the end of…
The AHA May 1 expressed concerns to the Centers for Medicare & Medicaid Services about the payment process established under the Medicare Drug Price Negotiation Program, explaining ways it undermines the purpose of the 340B Drug Pricing Program.
Congressional committees have begun marking up their portions of a reconciliation bill to enact key pieces of President Trump’s agenda.
340B Advocacy Alliance Bulletin for April 24, 2025.
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., April 24 released a report detailing findings from an investigation into how covered entities use and generate revenue from the 340B Drug Pricing Program.
The AHA appreciates Senator Cassidy’s leadership on 340B issues. As his report correctly observes, the 340B Program was created to help hospitals reach more eligible patients and provide more comprehensive services.
AHA 340B Advocacy Alliance Bulletin for April 22, 2025.
Johnson County Hospital is an 18-bed critical access hospital based in Tecumseh, Nebraska.
AHA, Others File Amicus Brief Challenging AbbVie in Defense of Louisiana's 340B Contract Pharmacy Law.
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.